Stocks to Watch: Contineum, Gap Inc., Geospace Technologies

Dow Jones11-21
 

By Katherine Hamilton

 

Contineum Therapeutics said its drug designed to treat multiple sclerosis didn't meet its trial endpoints. The stock fell 12%, to $10.75, in after-hours trading Thursday.

Gap Inc. raised its fiscal-year sales outlook after its three main brands logged same-store sales growth. Shares advanced 4.8%, to $24.16, after the bell.

Geospace Technologies said oil volatility and less offshore exploration resulted in an 11% drop in quarterly sales. The stock declined 11%, to $15.35.

 

Write to Katherine Hamilton at katherine.hamilton@wsj.com

 

(END) Dow Jones Newswires

November 20, 2025 18:31 ET (23:31 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment